FRC Logo
Top Picks

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports

© 2025 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Content
Screener
Top Picks
Home🔹Latest Reports🔹Zepp Health Corporation🔹Revenue Dip, Cost-Cutting Success, Eyeing H2 Recovery
Zepp Health Corporation

Revenue Dip, Cost-Cutting Success, Eyeing H2 Recovery

ByFRC AnalystsAugust 26, 2024
Revenue Dip, Cost-Cutting Success, Eyeing H2 Recovery

Disclosure: Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports. See last page for other important disclosures, rating, and risk definitions.

Company Details

Sector
Technology
Industry
Consumer Electronics

Trading Information

Live Price
Loading...
Ticker & Exchange
ZEPP:NYSE

Rating and Key Data

•••
MetricsValue
Stock Price (08/26/24)US $0.73
Fair ValueUS $4.17
Risk3
52 Week RangeUS $0.52-2.10
Shares O/S (M)59
Market Cap. (M)US $43
Current Yield (%)N/A
P/E (forward)N/A
P/B0.1

Want to see the full analysis?

Subscribe for free to get exclusive insights and fair value data.

Already a subscriber?

Report Highlights

  • In Q2-2024, revenue was down 56% YoY, missing our estimate by 22% due to lower than anticipated unit sales. EBITDA remained negative, but improved due to higher gross margins, and lower operating expenses.
  • Revenue declined due to the discontinuation of several low-margin products, with new product launches skewed toward H2-2024, combined with softer global demand for smartwatches, and stronger competition.
  • Sources indicate that global smartwatch shipments declined by 9% YoY in Q2 amid slower global GDP growth. Additionally, average product pricing fell due to discounts driven by excess supply. Apple (NASDAQ: AAPL), the largest smartwatch maker, reported a 1% YoY decline in unit sales. That said, global smartwatch shipments are forecasted to surge by 5%-10% in 2024 (unchanged consensus estimates), driven by pent-up demand, increasing health awareness,  AI integration, and the rising popularity of wearables.
  • In Q2, Zepp maintained its spot as the sixth-largest player in the global smartwatch market by sales, trailing Apple, Garmin (NYSE: GRMN), Samsung (KOSE: A005930), Huawei, and Fitbit (Google/NASDAQ: GOOGL).
  • Zepp is forecasting a strong revenue rebound in H2-2024, fueled by a series of product upgrades and new releases, such as the T-Rex 3 outdoor smartwatch, and the Open Wearable Stereo (OWS) earbuds. For Q3, management is anticipating $45-$60M in revenue vs $41M in Q2. 
  • At the end of Q2, working capital, and investments, net of long-term debt, totalled $257M vs Zepp’s MCAP of $43M, implying that the shares are trading well below liquid assets. 
  • Despite a favorable outlook for H2, we are lowering our 2024 revenue and EPS forecasts due to weaker-than-expected Q2 results. We now expect EBITDA to turn positive next year, rather than this year.

Price Performance (1-year)

 

  YTD 12M
ZEPP -49% -36%
NYSE 12% 20%

 

Unit Sales & Other Key Metrics

In Q2-2024, shipments were down 66% YoY, to 1.3M units (Q1: down 66% YoY as well), 18% lower than our estimate.  As a result, revenue fell 56% YoY, missing our estimate by 22%

In line with industry standards, Zepp retains 70% of the retail price of its products as revenue, while retailers and distributors keep the remaining 30%.

Zepp does not disclose segmented results:

  • Smart wristbands, and watches, constitute 90%+ of revenue. 
  • Self-Branded Products - Europe & the Middle East account for 50% of sales, followed by North America (25%), China (10%), and the rest of the world (15%) 
  • Xiaomi (SEHK: 1810) Products – China accounts for 70% of sales for this segment. In addition to its own portfolio of products, Zepp manufactures wearables for Xiaomi, the second largest wearables technology company, behind Apple. Xiaomi owns 20% of Zepp’s outstanding shares. Zepp's dependence on Xiaomi has been waning, as evidenced by the declining share of total revenue contributed by Xiaomi.

Self-branded unit shipments fell 36% YoY (Q1: down 60%), amid Zepp halting production of several low-margin products. This strategic move paid off as EBITDA improved by 6% despite a 56% YoY decrease in revenue 

Gross margins were up 18 pp to 40%, beating our estimate by 3 pp. Gross margins on self-branded units spiked 16 pp to 44%, well exceeding the sector average of 24%, and  approaching Apple's 45%

Zepp spent 26% of revenue on sales/marketing expenses, while Apple typically spends <5%. Operating expenses were down 16% YoY, but 9% higher than our estimate

EBITDA remained negative, but improved due to higher gross margins and lower operating expenses

 

 

Working capital, and investments, net of long-term debt was $257M vs the current MCAP of just $43M, implying that ZEPP is trading well below liquid assets 

 

FRC Projections and Valuation 

Zepp’s products (Amazfit) accounted for 2.8% of global smartwatch shipments in 2023. It is estimated that global smartwatch shipments will increase by 9% p.a. in 2024 (Source: Statista)

Historically, Zepp's revenue growth rate has averaged 1.6x the global growth rate. Due to Q2 falling short of expectations, we are substantially reducing our revenue and EPS forecasts

We now anticipate EBITDA will turn positive next year instead of this year

As a result, our DCF valuation decreased from $3.78 to $3.48/share

 

Comparables Valuation

ZEPP remains the most undervalued stock on our list of comparables. Given the company’s negative enterprise value, its shares are trading at -0.01x forward revenue (previously -0.08x) vs the sector average of 2.23x (previously 2.24x)

Applying 2.23x to our 2024 revenue forecast for Zepp, we arrived at a comparables valuation of $4.87/share (previously $6.61/share)

 

We are reiterating our BUY rating, and adjusting our fair value estimate from $5.19 to $4.17/share (the average of our DCF and comparables valuations). We maintain our view that Zepp is an attractive acquisition target for larger players like Xiaomi. We look forward to the market reaction to the upcoming product upgrades and new releases. 

 

Risks

We are assigning a risk rating of 3 (Average)

We believe the company is exposed to the following key risks (not exhaustive):

  • Competition and innovation
  • Supply chain vulnerabilities
  • Reliance on third-party manufacturers
  • Officers, directors, and principal shareholders hold 95% of total voting power
  • Need to always allocate substantial budgets for marketing
  •  
  • ZEPP is trading below $1/share, violating NYSE’s listing standards. The company has until November 2024 to comply or face delisting. To regain compliance, ZEPP is implementing a share buyback program and, if necessary, a reverse stock split.

 

 

 

Rating and Key Data

•••
MetricsValue
Stock Price (08/26/24)US $0.73
Fair ValueUS $4.17
Risk3
52 Week RangeUS $0.52-2.10
Shares O/S (M)59
Market Cap. (M)US $43
Current Yield (%)N/A
P/E (forward)N/A
P/B0.1

Want to see the full analysis?

Subscribe for free to get exclusive insights and fair value data.

Already a subscriber?

Related Content

Analysts' Ideas of the Week

Gold and Critical Metal Juniors Make Headlines

December 15, 2025
Thumbnail for Gold and Critical Metal Juniors Make Headlines
Analysts' Ideas of the Week

Glencore Investment & Updates from Energy Storage, Gold, and Silver Companies

December 9, 2025
Thumbnail for Glencore Investment & Updates from Energy Storage, Gold, and Silver Companies
Analysts' Ideas of the Week

Silver Junior Reports Bonanza Values & Lithium Top Pick Surges Again

December 2, 2025
Thumbnail for Silver Junior Reports Bonanza Values & Lithium Top Pick Surges Again
Analysts' Ideas of the Week

Top Pick Gains & Equity Financings

November 24, 2025
Thumbnail for Top Pick Gains & Equity Financings